drugset
drugset / Trial / NCT01153750

Efficacy of Imatinib and 5-FU/Leucovorin in Patients With Advanced Carcinoma of the Gallbladder and Bile Duct

NCT01153750 ↗

Phase 2 Completed 44 enrolled University Hospital Dresden
Non-randomizedSingle-groupOpen-labelTreatment

Summary

To test the efficacy of a combination chemotherapy of imatinib and 5-FU in advanced or metastatic cholangiocellular carcinoma.

Timeline

Start
2007-04
Primary completion
2010-03
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Imatinib Small molecule 600 mg —

Indications

cholangiocarcinoma